NGS testing

DIAGNOSTIC_TEST4 trials

Sponsors

The Belgian Society of Medical Oncology, National Cancer Institute (NCI), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, AstraZeneca

Conditions

Acute Lymphoblastic LeukemiaB-AllEssential ThrombocythaemiaLocal Tumor InvasionMetastatic CancerMyelofibrosisNon-Small Cell Lung CancerPolycythemia Vera

Unknown Phase

A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center

The Belgian Society of Medical OncologyLocal Tumor Invasion, Metastatic Cancer

Start: 2020-10-09End: 2022-12-31Target: 1000Updated: 2021-05-28

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

RecruitingNCT05621291

National Cancer Institute (NCI)Acute Lymphoblastic Leukemia, B-All

Start: 2026-09-22End: 2027-12-31Target: 60Updated: 2026-09-17

Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History

Not yet recruitingNCT06923670

Fondazione Policlinico Universitario Agostino Gemelli IRCCSEssential Thrombocythaemia, Myelofibrosis, Polycythemia Vera

Start: 2025-05-21End: 2028-05-01Target: 496Updated: 2025-05-15

A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet)

RecruitingNCT07613424

AstraZenecaNon-Small Cell Lung Cancer

Start: 2026-06-02End: 2027-03-31Target: 1000Updated: 2026-07-14